About CAS Medical Systems (NASDAQ:CASM)
CAS Medical Systems, Inc. is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products for patient care. The Company designs, manufactures and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It operates through Tissue Oximetry Monitoring, which includes sales of its FORE-SIGHT tissue oximeter monitors, sensors and accessories. The FORE-SIGHT Tissue Oximeter technology provides clinicians a non-invasive, quantitative measurement of oxygenation in cerebral tissue.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Advanced Medical Equipment & Technology
- Sub-Industry: N/A
- Symbol: NASDAQ:CASM
- CUSIP: N/A
- Web: www.casmed.com
- Market Cap: $21.86 million
- Outstanding Shares: 27,329,000
- 50 Day Moving Avg: $0.88
- 200 Day Moving Avg: $1.06
- 52 Week Range: $0.74 - $1.94
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -4.71
- P/E Growth: -0.19
- Annual Revenue: $22.24 million
- Price / Sales: 0.98
- Book Value: ($0.49) per share
- Price / Book: -1.63
- EBITDA: ($4,050,000.00)
- Net Margins: -32.59%
- Return on Assets: -47.68%
- Debt-to-Equity Ratio: -0.48%
- Current Ratio: 1.86%
- Quick Ratio: 1.62%
- Average Volume: 42,488 shs.
- Beta: -1.11
- Short Ratio: 5.07
Frequently Asked Questions for CAS Medical Systems (NASDAQ:CASM)
What is CAS Medical Systems' stock symbol?
CAS Medical Systems trades on the NASDAQ under the ticker symbol "CASM."
How were CAS Medical Systems' earnings last quarter?
CAS Medical Systems, Inc. (NASDAQ:CASM) released its quarterly earnings data on Tuesday, August, 8th. The company reported ($0.09) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.07) by $0.02. The company had revenue of $4.57 million for the quarter, compared to the consensus estimate of $5.41 million. View CAS Medical Systems' Earnings History.
When will CAS Medical Systems make its next earnings announcement?
Who are some of CAS Medical Systems' key competitors?
Some companies that are related to CAS Medical Systems include Advanced Oncotherapy PLC (AVO), EnteroMedics (ETRM), Xtant Medical Holdings (XTNT), Dynatronics Corporation (DYNT), Dextera Surgical (DXTR), PhotoMedex (PHMD), Alliance HealthCare Services (AIQ), BIOLASE (BLTI), Cynosure (CYNO), Derma Sciences (DSCI), Hansen Medical (HNSN), Lifeline Scientific (LSIC), Mindray Medical International Ltd (MR), Nanosphere (NSPH), Sirona Dental Systems (SIRO), Sphere Medical Holding PLC (SPHR), Synergetics USA (SURG) and Thoratec (THOR).
Who are CAS Medical Systems' key executives?
CAS Medical Systems' management team includes the folowing people:
- Thomas M. Patton, President, Chief Executive Officer, Director
- Jeffrey A. Baird, Chief Financial Officer, Secretary
- Kimberly K. Strusky, Executive Vice President - U.S. Sales
- Paul B. Benni, Chief Scientific Officer
- John K Gamelin Ph.D., Vice President - Research & Development
- James E. Thomas, Lead Independent Director
- Alan W. Milinazzo, Director
- Paul A. Molloy, Director
- Gregory P. Rainey, Independent Director
- Kathleen A. Tune, Independent Director
How do I buy CAS Medical Systems stock?
Shares of CAS Medical Systems can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CAS Medical Systems' stock price today?
MarketBeat Community Rating for CAS Medical Systems (NASDAQ CASM)MarketBeat's community ratings are surveys of what our community members think about CAS Medical Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of CAS Medical Systems stock can currently be purchased for approximately $0.80.
Consensus Ratings for CAS Medical Systems (NASDAQ:CASM) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|Consensus Price Target History for CAS Medical Systems (NASDAQ:CASM)
Analysts' Ratings History for CAS Medical Systems (NASDAQ:CASM)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for CAS Medical Systems (NASDAQ:CASM)Earnings History by Quarter for CAS Medical Systems (NASDAQ CASM)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/8/2017||Q2 2017||($0.07)||($0.09)||$5.41 million||$4.57 million||View||Listen|
|5/3/2017||Q1 2017||($0.06)||($0.08)||$5.73 million||$5.23 million||View||Listen|
|3/9/2017||Q4 2016||($0.03)||($0.07)||$5.49 million||$5.48 million||View||Listen|
|11/8/2016||Q3||($0.05)||($0.06)||$5.85 million||$5.76 million||View||Listen|
|8/4/2016||Q2||($0.05)||($0.08)||$5.58 million||$5.50 million||View||N/A|
|5/5/2016||Q1||($0.06)||($0.03)||$5.88 million||$5.46 million||View||N/A|
|3/9/2016||Q4||($0.07)||($0.08)||$5.20 million||$5.80 million||View||Listen|
|11/5/2015||Q315||($0.09)||($0.08)||$5.66 million||$5.50 million||View||N/A|
|8/5/2015||Q215||($0.10)||($0.09)||$5.36 million||$5.80 million||View||N/A|
|5/5/2015||Q115||($0.10)||($0.08)||$5.21 million||$5.80 million||View||N/A|
|3/4/2015||Q414||($0.11)||($0.11)||$5.80 million||$5.80 million||View||N/A|
|11/4/2014||Q3 2014||($0.12)||($0.10)||$5.53 million||View||N/A|
|8/6/2014||Q214||($0.11)||($0.11)||$5.00 million||$5.80 million||View||N/A|
|5/1/2014||Q1 2014||($0.13)||($0.11)||$5.71 million||View||N/A|
|3/6/2014||Q413||($0.17)||($0.19)||$5.90 million||$5.90 million||View||N/A|
|11/12/2013||Q3||($0.19)||$6.10 million||$5.40 million||View||Listen|
|8/7/2013||Q2 2013||($0.22)||$5.20 million||$5.00 million||View||N/A|
|11/8/2012||Q312||($0.14)||$5.79 million||$6.11 million||View||N/A|
Earnings Estimates for CAS Medical Systems (NASDAQ:CASM)
2017 EPS Consensus Estimate: ($0.31)
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for CAS Medical Systems (NASDAQ:CASM)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for CAS Medical Systems (NASDAQ:CASM)
Insider Ownership Percentage: 36.00%Insider Trades by Quarter for CAS Medical Systems (NASDAQ:CASM)
Institutional Ownership Percentage: 24.71%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|1/26/2017||James E Flynn||Insider||Sell||636,238||$1.46||$928,907.48|| |
|1/23/2017||James E Flynn||Insider||Sell||205,126||$1.53||$313,842.78|| |
|5/15/2015||Brian J Wagner||Insider||Buy||2,032||$1.31||$2,661.92|| |
|2/11/2015||Thomas M Patton||CEO||Buy||40,000||$1.30||$52,000.00|| |
|2/11/2015||Thomas, Mcnerney & Partners Ii||Major Shareholder||Buy||1,605,000||$1.30||$2,086,500.00|| |
|9/2/2014||Thomas M Patton||CEO||Buy||1,500||$1.48||$2,220.00|| |
|8/18/2014||Thomas M Patton||CEO||Buy||10,000||$1.54||$15,400.00|| |
|8/8/2014||Thomas M Patton||CEO||Buy||10,000||$1.61||$16,100.00|| |
|8/21/2013||Thomas M Patton||CEO||Buy||5,300||$1.42||$7,526.00|| |
|9/6/2012||Thomas M Patton||CEO||Buy||10,332||$1.88||$19,424.16|| |
Headline Trends for CAS Medical Systems (NASDAQ:CASM)
Latest Headlines for CAS Medical Systems (NASDAQ:CASM)
Loading headlines, please wait.
CAS Medical Systems (CASM) Chart for Monday, October, 23, 2017